IDH1 and central nervous system cancer: A recent study of paired primary and recurrent IDH-mutant gliomas reported that in some cases allelic imbalances of the IDH-mutant allele occurred upon recurrence, which led to a change in mutant protein expression and consequently decreased 2HG production [145].